Literature DB >> 23873207

Rapid and sensitive online determination of some selective α1-blockers by flow injection analysis with micelle-enhanced fluorescence detection.

Niveen A Mohamed1, Sameh Ahmed, Sally A El Zohny.   

Abstract

A rapid, sensitive and selective flow injection analysis (FIA) method was developed for the determination of some selective α1-blockers including; terazosin (TER), doxazosin (DOX), prazosin (PRZ), and alfuzosin (ALF). The method was based on enhancement of the native fluorescence of the studied drugs in the presence of sodium dodecyl sulfate (SDS). The method was optimized for the buffer type, concentration and pH, surfactant type and concentration, flow rate and detection wavelengths in order to achieve the maximum sensitivity. The results showed that the best sensitivity was obtained by using SDS (10 mM) in phosphate buffer (20 mM, pH = 3), flow rate was 0.5 ml/min and the detector was set at λex = 250 and λem = 389. Under these optimum conditions there was a linear relationship between the concentration and the fluorescence intensity in the range from 5-400 ng ml(-) with correlation coefficient of more than 0.998. The detection and quantitation limits for the studied drugs by the proposed method were 3.2-11.9 ng ml(-1) and 10.8-39.7 ng ml(-1), respectively. The method was validated in accordance with the requirements of ICH guidelines and shown to be suitable for intended applications. Moreover, the binding constants for α1-blockers -SDS system were determined using the adduct model. The proposed method has been applied successfully for the analysis of the pure forms for studied drugs and also their pharmaceutical formulations and the results were compared with official methods.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23873207     DOI: 10.1007/s10895-013-1264-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  23 in total

1.  Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.

Authors:  Monika Bakshi; Tina Ojha; Saranjit Singh
Journal:  J Pharm Biomed Anal       Date:  2004-01-27       Impact factor: 3.935

2.  Validated RP-HPLC and TLC methods for simultaneous estimation of tamsulosin hydrochloride and finasteride in combined dosage forms.

Authors:  Dipti B Patel; Natubhai J Patel
Journal:  Acta Pharm       Date:  2010-06       Impact factor: 2.230

3.  Guidelines from the International Conference on Harmonisation (ICH).

Authors:  Sarah K Branch
Journal:  J Pharm Biomed Anal       Date:  2005-08-10       Impact factor: 3.935

4.  Flow injection analysis of doxazosin mesylate using UV-detection.

Authors:  G Altiokka; Z Atkosar
Journal:  J Pharm Biomed Anal       Date:  2002-02-01       Impact factor: 3.935

5.  Prazosin determination by high-pressure liquid chromatography using fluorescence detection.

Authors:  Y G Yee; P C Rubin; P Meffin
Journal:  J Chromatogr       Date:  1979-04-21

6.  Determination of polythiazide and prazosin in human plasma by high-performance liquid chromatography.

Authors:  J Dokladalova; S J Coco; P R Lemke; G T Quercia; J J Korst
Journal:  J Chromatogr       Date:  1981-06-12

7.  Enantiomeric resolution of doxazosin mesylate and its process-related substances on polysaccharide chiral stationary phases.

Authors:  R Nageswara Rao; D Nagaraju; A Narasa Raju
Journal:  J Pharm Biomed Anal       Date:  2006-02-21       Impact factor: 3.935

8.  Liquid chromatographic analysis of doxazosin in human serum with manual and robotic sample preparation.

Authors:  H G Fouda; T M Twomey; R P Schneider
Journal:  J Chromatogr Sci       Date:  1988-11       Impact factor: 1.618

9.  High-performance liquid chromatography using electrochemical detection for the determination of prazosin in biological samples.

Authors:  A Rathinavelu; A Malave
Journal:  J Chromatogr B Biomed Appl       Date:  1995-08-04

10.  A LC-MS-MS method for determination of low doxazosin concentrations in plasma after oral administration to dogs.

Authors:  Marijana Erceg; Mario Cindric; Lidija Pozaic Frketic; Maria Vertzoni; Biserka Cetina-Cizmek; Christos Reppas
Journal:  J Chromatogr Sci       Date:  2010-02       Impact factor: 1.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.